VolitionRx Limited (VNRX)
AMEX: VNRX
· Real-Time Price · USD
0.60
-0.00 (-0.02%)
At close: Sep 26, 2025, 10:58 AM
-0.02% (1D)
Bid | 0.59 |
Market Cap | 64.42M |
Revenue (ttm) | 1.32M |
Net Income (ttm) | -23.32M |
EPS (ttm) | -0.24 |
PE Ratio (ttm) | -2.5 |
Forward PE | -8.51 |
Analyst | Buy |
Dividends | n/a |
Ask | 0.61 |
Volume | 52,790 |
Avg. Volume (20D) | 176,609 |
Open | 0.60 |
Previous Close | 0.60 |
Day's Range | 0.60 - 0.61 |
52-Week Range | 0.40 - 0.94 |
Beta | 1.27 |
Ex-Dividend Date | n/a |
About VNRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VNRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VNRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsVolitionRx Limited is scheduled to release its earnings on
Nov 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+7.94%
VolitionRx shares are trading higher after the com...
Unlock content with
Pro Subscription
5 months ago
+7.39%
VolitionRX shares are trading higher on possible continued strength after HC Wainwright & Co. initiated coverage on the stock yesterday with a Buy rating and announced a price target of $2.5.